ReviewBreast care (Basel, Switzerland)2016

Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer.

Johannes EttlPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.